
Shareholding18 Aug 2026, 11:31 am
Piramal Pharma: Deutsche Bank Releases 7.39% Pledged Shares
AI Summary
Deutsche Bank AG, acting as the onshore security agent, has disclosed the release of 98,400,000 equity shares of Piramal Pharma Limited. These released shares constitute 7.39% of the total issued and paid-up share capital. This action is part of a 'Permitted Sale Transaction' under a facility agreement. Following this release, Deutsche Bank continues to hold a pledge over 140,263,700 equity shares, representing 10.54% of the company's share capital. The disclosure is made under SEBI's Takeover Regulations.
Key Highlights
- Deutsche Bank released 7.39% of Piramal Pharma's shares from pledge.
- Remaining pledged shares now represent 10.54% of the company's capital.
- The release is part of a 'Permitted Sale Transaction'.
- Disclosure made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- Deutsche Bank acts as pledgee, not beneficial owner of pledged shares.
Price Impact
More from PPLPHARMA